Home › Funds › Palo Alto Investors LP › VSTM
Palo Alto Investors LP position in VSTM
VERASTEM INC · Health Care
Palo Alto Investors LP reported holding 325,480 shares of VSTM (VERASTEM INC) in its Q3 2026 13F filing — a position valued at US$2.6M, representing 0.39% of its reported portfolio and ranking #33 among its reported holdings. Palo Alto Investors LP has disclosed VSTM holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Palo Alto Investors LP's VSTM position evolved
Palo Alto Investors LP first disclosed a stake in VSTM in Q1 2026 at 246,093 shares (US$1.3M). The position peaked in Q3 2026 at 325,480 shares, worth US$2.6M. Across 3 filings, Palo Alto Investors LP increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 325,480 shares valued at US$2.6M — an increase of 15,795 shares quarter over quarter.. Notable position changes include a 26% increase in Q2 2026 (shares rose 111% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 246.09K | $1.30M | New |
| Q2 2026 | 309.69K | $1.18M | Add |
| Q3 2026 | 325.48K | $2.62M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About VSTM and 13F data
VSTM (VERASTEM INC) is a Health Care company. 44 other funds we track also report a position in VSTM — the largest reported positions include RTW INVESTMENTS, LP (US$54.1M), Deep Track Capital, LP (US$46.2M), ARMISTICE CAPITAL, LLC (US$46.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding VSTM
- RTW INVESTMENTS, LP 6.72M sh · $54.08M · Q3 2026
- Deep Track Capital, LP 5.74M sh · $46.21M · Q3 2026
- ARMISTICE CAPITAL, LLC 5.72M sh · $46.08M · Q3 2026
- MPM BioImpact LLC 3.85M sh · $31.01M · Q3 2026
- Foresite Capital Management VI LLC 3.15M sh · $25.33M · Q3 2026
- Stonepine Capital Management, LLC 3.04M sh · $24.49M · Q3 2026
- ACORN CAPITAL ADVISORS, LLC 1.47M sh · $11.83M · Q3 2026
- AIGH Capital Management LLC 1.12M sh · $9.03M · Q3 2026
- NEXTBio Capital Management LP 906.74K sh · $7.30M · Q3 2026
- Opaleye Management Inc. 1.80M sh · $6.88M · Q2 2026
- TORRAY INVESTMENT PARTNERS LLC 464.38K sh · $3.74M · Q3 2026
- Exome Asset Management LLC 429.04K sh · $3.45M · Q3 2026
More on Palo Alto Investors LP
FAQ
How long has Palo Alto Investors LP held VSTM?
Palo Alto Investors LP has disclosed VSTM holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
What is Palo Alto Investors LP's current position in VSTM?
As of Q3 2026, Palo Alto Investors LP holds 325.48K shares of VSTM (VERASTEM INC), valued at $2.62M, representing 0.39% of its reported portfolio and ranking #33.
Has Palo Alto Investors LP been buying or selling VSTM?
In the latest 13F filing (Q3 2026), Palo Alto Investors LP increased its position in VSTM. The position peaked in Q3 2026 at 325.48K shares.
Which other funds hold VSTM?
Other major institutional holders of VSTM include RTW INVESTMENTS, LP, Deep Track Capital, LP, ARMISTICE CAPITAL, LLC, among 44 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.